(Q43792800)

26 November 2017

title

Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells (English)

1 reference

26 November 2017

Rugstad HE

1

1 reference

26 November 2017

Glennås A

series ordinal

2

1 reference

26 November 2017

publication date

1 January 1988

1 reference

Scandinavian Journal of Rheumatology

26 November 2017

published in

1 reference

26 November 2017

volume

17

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

175-181

1 reference

Acquired resistance to auranofin in cultured human cells.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

Cultured human cells can acquire resistance to the antiproliferative effect of sodium aurothiomalate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

Metallothionein in cultured human epithelial cells and synovial rheumatoid fibroblasts after in vitro treatment with auranofin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

Clinical pharmacokinetics of oral and injectable gold compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

The cellular pharmacology of auranofin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

Inhibitory effects of a new oral gold compound on hela cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009748809098780

10.3109/03009748809098780

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference